COVID-19 to Lead the Sales of Dural Graft Market to Register Stellar Growth in the Next 10 Years
Since the COVID-19 infection flare-up in December 2019, the malady has spread to right around 100 nations around the world with the World Health Organization proclaiming it a general wellbeing crisis. The worldwide effects of the coronavirus sickness 2019 (COVID-19) are now beginning to be felt, and will essentially influence the Healthcare Industry in 2020.
Global demand for dural graft is expected to grow significantly, owing to rising burden of neurosurgical diseases leading to increasing cranial and spinal duraplasty, and rapid technological advancements in dural graft products.
Moreover, increasing global neurosurgical workforce, extensive clinical research, and increasing demand for CNS dural repair are responsible for increasing the adoption of dural graft products.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/25285
Company Profiles
- Cook Medical.
- Integra Lifesciences Corporation
- B Braun
- Cousin Biotech,
- Natus Medical Incorporated
- Tissuemed Ltd,
- Vostra GmbH
- Stryker Corporation
- Medtronic Plc.
- Johnson & Johnson,
- Aesculap, Inc.
- Baxter International Inc
For instance, in 2004, the World Health Organization (WHO) estimated that, there were 33,193 neurosurgeons worldwide, including trainees. Whereas, in 2015, this number rose to approximately 49,940 neurosurgeons, with a 4% total growth, worldwide.
Persistence Market Research predicts that, the global dural graft market will exhibit a 6% CAGR during the forecast period (2019-2029).
Key Takeaways of Dural Graft Market Study
- By product type, synthetic dural graft along with xenogeneic dural graft are expected to gain traction during the forecast period.
- Technological advancements in material science of dural graft products in North America and Europe are expected to contribute to the significant dominance of these regions during the forecast period.
- Brain and spine tumor applications are expected to hold more than 50% share in the global dural graft market.
- Synthetic polymer material is expected to gain significant traction and experience 2X demand by 2029.
- Leading dural graft manufacturing companies are partnering with innovative product developers and specialized distributors to strengthen their market position.
- Rising healthcare expenditure and increasing neurosurgeon workforce density in East Asia are expected to offer significant opportunities for market growth.
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/25285
“Increasing scientific evidence from industry-led clinical trials and technological advancements in dural graft products are expected to support the significant adoption of synthetic nanofibrous dural grafts.” says a PMR analyst.
Brain and Spinal Tumor Application Dominating Dural Graft Market
Prevalence of CNS tumors due to neurological conditions is growing rapidly. Chiari malformation and spinal cord tumor-related neurosurgical procedures requiring dural grafts for surgeries are becoming more frequent. Growing risk of such neurological conditions demands neurosurgical procedures along with duraplasty for effective and safe treatment outcomes.
For instance, in 2018, more than 50% of dural grafts were used in cranial and spine tumor operations. This high proportion is estimated to continue in the future.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/25285
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the dural graft market in its latest study, presenting historical demand assessment from 2014-2018 and projections for 2019-2029, on the basis of product type (xenogeneic dural graft, synthetic dural graft, autologous dural graft, and allogeneic dural graft), application (brain and spine tumor, traumatic brain and spine injury, cerebrospinal fluid (CSF) accumulation, cerebrovascular accident, epilepsy, and others), material (bovine pericardium, autologous pericardium, synthetic polymers, ligamentum nuchae, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and clinics), across seven key regions.
What the report encloses for the readers:
- Critical insights of each segment, including volume growth outlook, and demand & supply pattern.
- A to Z of each player –positives & negatives, current status, future developments – of the global market.
- Detailed information regarding the trends influencing the growth of the global market.
- In-depth assessment on the utilization in the industry.
- Historical data and future growth outlook of the global market.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Opioids Market – Opioids Market Segmented By Morphine, Codeine, Fentanyl, Meperidine, Methadone Product in Analgesia, Cough Suppression, Diarrhea Suppression. For More Information
Non Infectious Macular Edema Treatment Market – Non-infectious Macular Edema Treatment Market Segmented By Anti-VEGF, Corticosteroids, Immunosuppressant, Biologics Drug with Non-infectious Uveitic Macular Edema, Diabetic Macular Edema, Retinal Vein Occlusion with Macular Edema Indication by Oral, Parenteral, Topical Route of Administration. For More Information
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com